Last quarter (Q ), Polydex Pharmaceuticals's total revenue was $1.06M, an increase of 13.91% from the same quarter last year. In Q, Polydex Pharmaceuticals's net income was $-1.37M. See Polydex Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jan 10	Jan 09	Jan 08	Jan 07	Jan 06
Total Revenue	$ 4.48M	$ 4.48M	$ 4.82M	$ 5.73M	$ 6.50M	$ 5.27M
Cost of Revenue	$ 4.57M	$ 4.57M	$ 4.79M	$ 5.36M	$ 5.67M	$ 4.84M
Gross Profit	$ -91.72K	$ -91.72K	$ 31.90K	$ 375.06K	$ 832.44K	$ 429.19K
Operating Expense	$ 1.10M	$ 1.10M	$ 1.14M	$ 1.39M	$ 1.63M	$ 1.82M
Operating Income	$ -1.19M	$ -1.19M	$ -1.11M	$ -1.01M	$ -801.57K	$ -1.39M
Net Non Operating Interest Income Expense	$ -43.44K	$ -43.44K	$ -56.35K	-	-	-
Other Income Expense	$ 144.94K	$ -914.50K	$ 478.67K	$ 37.79K	$ 22.88K	$ 13.56K
Pretax Income	$ -2.14M	$ -2.14M	$ -1.64M	$ -967.15K	$ -375.82K	$ -1.31M
Tax Provision	-	$ 0.00	$ -52.96K	$ -81.94K	$ -115.19K	$ 180.76K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -2.14M	$ -2.14M	$ -1.59M	$ -885.21K	$ -260.62K	$ -1.49M
Basic EPS	$ -0.71	$ -0.70	$ -0.52	$ -0.29	$ -0.09	$ -0.49
Diluted EPS	$ -0.71	$ -0.70	$ -0.52	$ -0.29	$ -0.09	$ -0.49
Basic Average Shares	$ 12.29M	$ 3.07M	$ 3.07M	$ 3.07M	$ 3.06M	$ 3.04M
Diluted Average Shares	$ 12.29M	$ 3.07M	$ 3.07M	$ 3.07M	$ 3.06M	$ 3.04M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 5.67M	$ 5.67M	$ 5.93M	$ 6.75M	$ 7.30M	$ 6.65M
Net Income From Continuing And Discontinued Operation	$ -2.14M	$ -2.14M	$ -1.59M	$ -885.21K	$ -260.62K	$ -1.49M
Normalized Income	$ -2.29M	$ -1.23M	$ -2.05M	$ -919.80K	$ -276.49K	$ -1.50M
Interest Expense	$ 54.62K	$ 54.62K	$ 66.71K	-	-	-
EBIT	$ -2.09M	$ -2.09M	$ -1.58M	$ -1.01M	$ -801.57K	$ -1.39M
EBITDA	$ -1.66M	$ -1.66M	$ -1.03M	$ -452.04K	$ -253.80K	$ -817.48K

Currency in USD

Polydex Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing